Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Early research (Phase 1)Study completedNCT02859857
What this trial is testing

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Bexion Pharmaceuticals, Inc. 86
Early research (Phase 1)UnknownNCT03231501
What this trial is testing

HMPL-813 in Treating Patients With Glioblastoma

Who this might be right for
Glioblastoma
Hutchison Medipharma Limited 29
Very early researchStudy completedNCT04391595
What this trial is testing

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaGBMGlioma
Nader Sanai 42
Testing effectiveness (Phase 2)Study completedNCT00433381
What this trial is testing

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 123
Testing effectiveness (Phase 2)Ended earlyNCT03382977
What this trial is testing

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Who this might be right for
Glioblastoma Multiforme
VBI Vaccines Inc. 70
Testing effectiveness (Phase 2)UnknownNCT00635557
What this trial is testing

Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Myrexis Inc. 30
Early research (Phase 1)WithdrawnNCT03480867
What this trial is testing

Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA)

Who this might be right for
Glioblastoma Multiforme, Adult
McGill University Health Centre/Research Institute of the McGill University Health Centre
Very early researchWithdrawnNCT05054400
What this trial is testing

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Who this might be right for
Brain MetastasesCancerGliomas+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07364786
What this trial is testing

Effect of Salovum® on Pressure, Oxygen and Inflammation in Glioblastoma

Who this might be right for
Glioblastoma
Peter Siesjö 10
Testing effectiveness (Phase 2)UnknownNCT03746288
What this trial is testing

To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM)

Who this might be right for
GBM
CANbridge Life Sciences Ltd. 60
Very early researchLooking for participantsNCT07655869
What this trial is testing

[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma

Who this might be right for
Recurrent High-Grade GliomasRecurrent Glioblastoma IDH Wildtype
Beijing Tiantan Hospital 24
Testing effectiveness (Phase 2)UnknownNCT00276783
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
Northwestern University 31
Early research (Phase 1)UnknownNCT05929456
What this trial is testing

Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)

Who this might be right for
GlioblastomaHigh-grade Glioma
University Medical Center Groningen 21
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Early research (Phase 1)Ended earlyNCT03296696
What this trial is testing

Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma

Who this might be right for
Glioblastoma or Malignant Glioma
Amgen 30
Testing effectiveness (Phase 2)Looking for participantsNCT07831369
What this trial is testing

VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma

Who this might be right for
GlioblastomaAstrocytoma, IDH-Mutant, Grade 4
Inova Health Care Services 52
Early research (Phase 1)UnknownNCT00083096
What this trial is testing

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 30
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT04114786
What this trial is testing

3D Printed Mask for GBM and Brain Mets

Who this might be right for
Brain Cancer
University Health Network, Toronto 40
Next Page